Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | 18,300 | reported | 08 Dec 2025 | tx 191+212,312−207,388 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 08 Dec 2025 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 992 | 712.94 USD | |
| 05 Dec 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 3,027 | 0.00 USD | |
| 05 Dec 2025 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 14,924 | 0.00 USD | deriv |
| 16 Dec 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 491 | 730.81 USD | |
| 06 Dec 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 2,591 | 0.00 USD | |
| 09 Dec 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 1,140 | 787.00 USD | |
| 06 Dec 2024 | GRANT_AWARD | REGENERON PHARMACEUTICALS, INC. | 9,979 | 0.00 USD | deriv |
| 28 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 228 | 1204.79 USD | |
| 28 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 766 | 1205.44 USD | |
| 28 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 200 | 1206.30 USD | |
| 28 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 2,237 | 1204.71 USD | |
| 28 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 200 | 1206.67 USD | |
| 28 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 450 | 1206.15 USD | |
| 28 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 236 | 1205.67 USD | |
| 28 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 200 | 1206.70 USD | |
| 28 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 235 | 1205.67 USD | |
| 28 Aug 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 928 | 1205.49 USD | |
| 09 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,342 | 953.47 USD | |
| 09 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 600 | 955.00 USD | |
| 09 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,100 | 954.57 USD | |
| 09 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 344 | 950.49 USD | |
| 09 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 487 | 951.39 USD | |
| 09 Feb 2024 | SALE | REGENERON PHARMACEUTICALS, INC. | 1,046 | 952.62 USD | |
| 23 Jan 2024 | EXERCISE | REGENERON PHARMACEUTICALS, INC. | 5,000 | 555.67 USD | |
| 23 Jan 2024 | TAX_WITHHOLDING | REGENERON PHARMACEUTICALS, INC. | 3,583 | 948.50 USD |